| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ABEONA THERAPEUTICS INC. | Chief Financial Officer | Common stock | 400,169 | $2,044,864 | $5.11 | 08 Oct 2021 | Direct |
| Dianthus Therapeutics, Inc. /DE/ | CHIEF ACCOUNTING OFFICER | Stock Option (Right to Buy) | 55,000 | 03 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 03 Feb 2026 | 1 | $0 | 4 | CHIEF ACCOUNTING OFFICER | 04 Feb 2026, 17:42 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 03 Feb 2025 | 1 | $0 | 4 | CHIEF ACCOUNTING OFFICER | 04 Feb 2025, 16:27 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 23 May 2024 | 1 | $0 | 4 | CHIEF ACCOUNTING OFFICER | 28 May 2024, 20:05 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 24 Jan 2024 | 1 | $0 | 4 | CHIEF ACCOUNTING OFFICER | 26 Jan 2024, 16:51 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 11 Sep 2023 | 0 | $0 | 3 | CHIEF ACCOUNTING OFFICER | 13 Sep 2023, 20:47 |
| ABEO | ABEONA THERAPEUTICS INC. | 08 Oct 2021 | 1 | -$30,596 | 4 | Chief Financial Officer | 08 Oct 2021, 20:29 |
| ABEO | ABEONA THERAPEUTICS INC. | 10 Aug 2021 | 2 | $0 | 4 | Chief Financial Officer | 12 Aug 2021, 16:05 |